China conditionally approves Linde/Praxair merger

China’s competition authority will allow Linde’s proposed $83 billion merger with Praxair based on structural and behavioural remedies, leaving the US and Korea as the last major jurisdictions yet to clear the deal.

Get unlimited access to all Global Competition Review content